Optimization of throughput and desorbent consumption in simulated moving-bed chromatography for paclitaxel purification.
In simulated moving-bed (SMB) applications, throughput and desorbent consumption are two key factors that control process cost. For a given adsorbent volume and product purity requirements, throughput and desorbent consumption depend on desorbent composition, column configuration, column length to diameter ratio, and adsorbent particle size. In this study, these design parameters are systematically examined for paclitaxel purification. The results show that if adsorbent particle size, column dimensions and column configuration are fixed, the higher the product purity required, the lower the throughput. If product purity and yield are fixed, the larger the solute migration speed ratio, the higher the throughput, and the lower the desorbent consumption. If total bed volume and product purities are fixed, the longer the separation zones, the higher the throughput, but the higher the desorbent flow-rate. An intermediate configuration gives the minimum desorbent consumption. If there are no limits on pressure drop or zone flow-rate, the larger the column length to diameter ratio, the smaller the adsorbent particle size, the higher the throughput, and the lower the desorbent consumption. If the maximum zone flow-rate is controlled by the pressure drop limit and not by the standing waves requirement, the longer the columns, the lower the zone flow-rates and the lower the throughput. For 150 microns adsorbent particles and a maximum zone flow-rate of 300 ml/min, a design with optimal throughput and desorbent consumption is found for paclitaxel purification.
Wu
D J
DJ
School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Ma
Z
Z
Wang
N H
NH
D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification*; D002853:Chromatography, Liquid / Q000379:methods*; D017239:Paclitaxel / Q000302:isolation & purification*; D010316:Particle Size
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel